Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Merck (Netherlands) | Researchclopedia

Back to institutions

Merck (Netherlands)

Amsterdamcompany

198

Works

66,191

Citations

81

h-index

Top Research Topics

Reproductive Biology and Fertility Computational Drug Discovery Methods Ovarian function and disorders

Top Researchers

John M. Kirkwood

1,347 works91,412 citationsh-index: 137

Recent Research

Single Spectral Flow Cytometry Panel for Simultaneous Detection of Hematopoietic Stem, Progenitor, and Mature Lineages in Mouse Bone Marrow

Léa Girondier,Manon Richaud,et al.

20260 citations

Multiple Sclerosis Research Studies

Cancer Immunotherapy and Biomarkers

Lung Cancer Treatments and Mutations

Receptor Mechanisms and Signaling

Melanoma and MAPK Pathways

Cancer-related gene regulation

Schizophrenia research and treatment

Neuroscience and Neuropharmacology Research

Blood Pressure and Hypertension Studies

Roger Stupp Northwestern University

838 works91,214 citationsh-index: 114

Stefan Zeuzem Goethe University Frankfurt

2,249 works90,310 citationsh-index: 129

John C. Cheville Mayo Clinic

951 works77,087 citationsh-index: 120

Florian Lordick Twitter (United States)

982 works47,833 citationsh-index: 91

Thai H. Ho Medical University of South Carolina

316 works47,366 citationsh-index: 64

P3.12.40 Safety and Patient-Reported Outcomes With Tepotinib in Patients With METex14 Skipping NSCLC: =3-Years Follow-Up of VISION

E. Felip,Rosarita Ferrara,et al.

20250 citations

1995P Treatment (Tx) sequencing of tepotinib in patients (pts) with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC): Outcomes from ≥3 years follow-up of the VISION study

S. Viteri,E. Felip,et al.

20250 citations

159. Cladribine Tablets Use in People with Multiple Sclerosis Up to 4 Years and Beyond Following Treatment Initiation: Results from Multi-country Patient Support Programmes

Jiwon Oh,Mavis Ayer,et al.

20240 citations

Analysis and Prediction of Chymotrypsin Substrate Preferences through Large Data Acquisition with Target‐Free mRNA Display

Sabrina E. Iskandar,Lindsey Guan,et al.

20241 citations

1555P Estimating the social value of immuno-oncology (IO) therapies in Japan

Tomoyoshi Ohno,Thomas J. Flottemesch,et al.

20240 citations